ECTRIMS eLearning

Identification of coping strategies in Multiple Sclerosis
Author(s): ,
E James
Affiliations:
Barts and The London School of Medicine, London
,
R.J Mills
Affiliations:
Royal Preston Hospital, Preston, United Kingdom
,
A Tennant
Affiliations:
Swiss Paraplegic Research, Nottwil, Switzerland
,
C.A Young
Affiliations:
Walton Centre NHS Trust;University of Liverpool, Liverpool, United Kingdom
TONiC Study Group
TONiC Study Group
Affiliations:
ECTRIMS Learn. James E. 09/16/16; 146695; P855
Eleanor James
Eleanor James
Contributions
Abstract

Abstract: P855

Type: Poster

Abstract Category: Clinical aspects of MS - Epidemiology

Background: The physical, psychological and social impacts of Multiple Sclerosis (MS) require the patient to develop coping strategies in order to address the adverse outcomes of the disorder. The aim of our study was to identify how coping strategies vary according to demographic and clinical factors.

Method: As part of the UK TONiC study, MS patients completed the Coping Orientation for Problem Experiences Scale (COPE60), consisting of 15 domains of coping skills, along with data on demographic and clinical characteristics. We generated mean frequencies of each coping domain using SPSS22, to compare use between gender, age, disability and disease type using the Mann-Whitney U Test.

Results: 722 patients completed the questionnaire, with an average age of 49 years (17-82); 519 females (71.9%). The most common coping strategies used were Acceptance (mean=7.20, SD=2.94) and Active Coping (6.47, 2.89); the least common were Substance Use (1.05, 2.30) and Denial (2.15, 2.42).

Patients aged < 50 years were found to use more Humour (z=-3.602, p=0.0003) and Substance Use (z=-3.076, p=0.002) as coping strategies; whereas those aged ≥50 years were more likely to use Religion (z=-3.508, p=0.0005), Restraint (z=-3.739, p=0.0002) and Suppression of Competing Activities (z=-2.38, p=0.017).

Women were more likely to use Focusing on and Venting of Emotions (z=-5.192, p< 0.00001), Religion (-2.014, p=0.044), and both Seeking Instrumental (z=-3.090, p=0.002) and Emotional Social Support (z=-4.732, p< 0.00001). Men used more Humour (z=-2.661, p=0.008) and Acceptance (z=-3.031, p=0.002).

Patients with an EDSS score ≥7 or who were progressive in their disease course used more Mental (z=-2.380, p=0.17) and Behavioural Disengagement (z=-2.850, p=0.004). Progressive patients were also more likely to use Restraint (z=-2.342, p=0.019) or Religion (z=-2.350, p=0.019), whereas relapsing patients were more likely to Seek Instrumental (z=-2.029, p=0.042) or Emotional Social Support (z=-2.462, p=0.014).

Conclusion: People with MS mainly favour an active, adaptive coping approach. However, different coping strategies are deployed depending on age, gender, disability and between progressive and relapsing patients. Older and more disabled patients are more likely to use an avoidant pattern of coping.



1. Carver CS, Scheier MF, Weintraub JK. Assessing Coping Strategies: A Theoretically Based Approach. J Personal Soc Psych 1989;56(2):267-283

Disclosure: Carolyn Young has received honoraria and travel expenses for scientific meetings and advisory boards, or grants from Bayer, Biogen Idec, Merck Serono, Genzyme, Motor Neurone Disease Association, MS Trust, National Institute for Health Research, Novartis, Roche, Teva, and Wellcome Trust. Roger Mills has received conference expenses from Biogen Idec and Teva. Eleanor James: nothing to disclose. Alan Tennant : nothing to disclose.

Abstract: P855

Type: Poster

Abstract Category: Clinical aspects of MS - Epidemiology

Background: The physical, psychological and social impacts of Multiple Sclerosis (MS) require the patient to develop coping strategies in order to address the adverse outcomes of the disorder. The aim of our study was to identify how coping strategies vary according to demographic and clinical factors.

Method: As part of the UK TONiC study, MS patients completed the Coping Orientation for Problem Experiences Scale (COPE60), consisting of 15 domains of coping skills, along with data on demographic and clinical characteristics. We generated mean frequencies of each coping domain using SPSS22, to compare use between gender, age, disability and disease type using the Mann-Whitney U Test.

Results: 722 patients completed the questionnaire, with an average age of 49 years (17-82); 519 females (71.9%). The most common coping strategies used were Acceptance (mean=7.20, SD=2.94) and Active Coping (6.47, 2.89); the least common were Substance Use (1.05, 2.30) and Denial (2.15, 2.42).

Patients aged < 50 years were found to use more Humour (z=-3.602, p=0.0003) and Substance Use (z=-3.076, p=0.002) as coping strategies; whereas those aged ≥50 years were more likely to use Religion (z=-3.508, p=0.0005), Restraint (z=-3.739, p=0.0002) and Suppression of Competing Activities (z=-2.38, p=0.017).

Women were more likely to use Focusing on and Venting of Emotions (z=-5.192, p< 0.00001), Religion (-2.014, p=0.044), and both Seeking Instrumental (z=-3.090, p=0.002) and Emotional Social Support (z=-4.732, p< 0.00001). Men used more Humour (z=-2.661, p=0.008) and Acceptance (z=-3.031, p=0.002).

Patients with an EDSS score ≥7 or who were progressive in their disease course used more Mental (z=-2.380, p=0.17) and Behavioural Disengagement (z=-2.850, p=0.004). Progressive patients were also more likely to use Restraint (z=-2.342, p=0.019) or Religion (z=-2.350, p=0.019), whereas relapsing patients were more likely to Seek Instrumental (z=-2.029, p=0.042) or Emotional Social Support (z=-2.462, p=0.014).

Conclusion: People with MS mainly favour an active, adaptive coping approach. However, different coping strategies are deployed depending on age, gender, disability and between progressive and relapsing patients. Older and more disabled patients are more likely to use an avoidant pattern of coping.



1. Carver CS, Scheier MF, Weintraub JK. Assessing Coping Strategies: A Theoretically Based Approach. J Personal Soc Psych 1989;56(2):267-283

Disclosure: Carolyn Young has received honoraria and travel expenses for scientific meetings and advisory boards, or grants from Bayer, Biogen Idec, Merck Serono, Genzyme, Motor Neurone Disease Association, MS Trust, National Institute for Health Research, Novartis, Roche, Teva, and Wellcome Trust. Roger Mills has received conference expenses from Biogen Idec and Teva. Eleanor James: nothing to disclose. Alan Tennant : nothing to disclose.

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies